Solenis, a global producer of specialty chemicals for water-intensive industries, dedicated its new world headquarters today just outside Wilmington. The 90,000-square-foot office replaces the company’s previous headquarters on Beaver Valley Road.
Located in the redeveloped Avenue North complex, the new two-story building is designed for sustainability and employee well-being. With features such as automatic lighting adjustment, wellness rooms, a fitness center and plenty of natural light, the building provides a comfortable and collaborative workspace. Avenue North is the former AstraZeneca campus.
“More than 200 employees have relocated to the building and there’s ample room to facilitate the growth we expect,” said Solenis senior vice president and chief financial officer, Philip M. Patterson, Jr. Executives, global managers and company departments such as human resources, marketing, IT and customer service reside in this location. The $3 billion specialty chemical company employs over 5,200 professionals in 120 countries spanning five continents.
Avenue North is an upscale mixed-use campus that combines office, commercial, residential and hotel uses. Solenis’ decision to relocate there was announced exactly one year ago when the company reaffirmed its commitment to remain in Delaware.
“Solenis is in a growth mode,” said Patterson. “We are working to retain, recruit and add employees to enhance our value proposition and better serve our customers. Our roots are here in Delaware and we are excited about continuing to grow here with our new headquarters.”
Solenis has received grants from the State of Delaware that are tied to employment in the state Solenis also has a research center in suburban Wilmington
For more information visit solenis.com.
Solenis is a leading global producer of specialty chemicals for pulp, paper, oil and gas, petroleum refining, chemical processing, mining, biorefining, power and municipal markets.
Solenis was formed with the sales of operations of Ashland, formerly Hercules to private equity investors. The company has since made a major acquisition of product lines from German chemical giant BASF.